September 8, 2017

Ginolis’ rapid test assembly system going to the US

A key feature of the Ginolis LSDA system is that it's easily adaptable and can assemble different rapid tests with minimal product specific adjustments.
A key feature of the Ginolis LSDA system is that it's easily adaptable and can assemble different rapid tests with minimal product specific adjustments.
Ginolis

Finnish automation solutions supplier Ginolis has agreed to deliver a Ginolis Lateral Flow Device Assembly (LFDA) system to Chembio Diagnostics’ headquarters in Medford, New York.

Chembio Diagnostics deals in rapid diagnostics tests for the healthcare sector and the Ginolis LFDA system will provide them with cost efficient assembly of rapid tests with high quality assurance.

Chembio will specifically use the system to automate its patented Dual Path Platform (DPP) technology, which can simultaneously detect both antigen and antibody in a disposable rapid test format.

“Ginolis sees intelligent automation as the future of diagnostics production,” says Jorma Venäläinen, Ginolis VP of sales and marketing. “By being able to assemble multiple products with the same system, manufacturers save valuable space in their clean room environments. We are excited about working together with Chembio and delivering the first six module LFDA to USA.”

Share: